HROWHarrow Health, Inc.Aug 11, 2026Q2 2026
Read transcript →Harrow Health, Inc. (HROW) Earnings Call Transcripts
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$34.57
-5.40%
Mkt Cap $1.41B
HROWHarrow Health, Inc.Aug 11, 2026HROWHarrow Health, Inc.May 12, 2026Q1 2026
Read transcript →HROWHarrow Health, Inc.Mar 3, 2026Q4 2025
Read transcript →HROWHarrow Health, Inc.Nov 11, 2025Q3 2025
Read transcript →HROWHarrow Health, Inc.Aug 12, 2025Q2 2025
Read transcript →HROWHarrow Health, Inc.May 10, 2025Q1 2025
Read transcript →HROWHarrow Health, Inc.Nov 14, 2024Q3 2024
Read transcript →HROWHarrow Health, Inc.Aug 8, 2024Q2 2024
Read transcript →HROWHarrow Health, Inc.May 14, 2024Q1 2024
Read transcript →HROWHarrow Health, Inc.Mar 20, 2024Q4 2023
Read transcript →HROWHarrow Health, Inc.Nov 13, 2023Q3 2023
Read transcript →HROWHarrow Health, Inc.Aug 9, 2023Q2 2023
Read transcript →HROWHarrow Health, Inc.May 11, 2023Q1 2023
Read transcript →HROWHarrow Health, Inc.Mar 23, 2023Q4 2022
Read transcript →HROWHarrow Health, Inc.Nov 14, 2022Q3 2022
Read transcript →HROWHarrow Health, Inc.Aug 13, 2022Q2 2022
Read transcript →HROWHarrow Health, Inc.May 8, 2022Q1 2022
Read transcript →HROWHarrow Health, Inc.Mar 10, 2022Q4 2021
Read transcript →HROWHarrow Health, Inc.Nov 9, 2021Q3 2021
Read transcript →HROWHarrow Health, Inc.Aug 10, 2021Q2 2021
Read transcript →HROWHarrow Health, Inc.May 11, 2021Q1 2021
Read transcript →HROWHarrow Health, Inc.Mar 8, 2021Q4 2020
Read transcript →HROWHarrow Health, Inc.Nov 9, 2020Q3 2020
Read transcript →HROWHarrow Health, Inc.Aug 10, 2020Q2 2020
Read transcript →HROWHarrow Health, Inc.May 11, 2020Q1 2020
Read transcript →HROWHarrow Health, Inc.Mar 13, 2020Q4 2019
Read transcript →HROWHarrow Health, Inc.Nov 13, 2019Q3 2019
Read transcript →HROWHarrow Health, Inc.Aug 14, 2019Q2 2019
Read transcript →HROWHarrow Health, Inc.May 12, 2019Q1 2019
Read transcript →HROWHarrow Health, Inc.Mar 12, 2019Q4 2018
Read transcript →HROWHarrow Health, Inc.Nov 13, 2018Q3 2018
Read transcript →HROWHarrow Health, Inc.Aug 6, 2018Q2 2018
Read transcript →